Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

Biotechnology

Immuneering

Ben Zeskind

Jan De Jong

Danielle Flannery

Edward Slezinger

Anastasia Gutierrez

Amy Axel

Melissa Martin

Dominique Hinds

Harold E.B. Brakewood

Max Peterson

Alex Peterson

Pedram Banishahabadi

Leah Neufeld

Michael Bookman

Mallory Morales

Brett Hall

Scientific Research Team

Leadership Team

Scientific Team

Legal and Administrative Team

Scientific Advisory Team

Operations Team

Teams at Immuneering